The study is devoted to the use of ketamine infusion in a subanesthetic dose in the postoperative period in children after surgical correction of congenital heart defects in children.
The study will examine the safety and effectiveness for neuroprotection of subanesthetic doses of ketamine in the postoperative period in children undergoing operations to correct septal congenital heart defects using cardiopulmonary bypass.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
196
ketamine infusion at a dose of 0.1 mg/kg/hour for 16 hours
ketamine infusion at a dose of 0.3 mg/kg/hour for 16 hours
Without ketamine
Artem Ivkin
Kemerovo, Please Select, Russia
RECRUITINGBiomarkers
monitoring the concentration of markers of brain damage at several control points
Time frame: 16 hours after operation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.